Associated Papers
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.
Tan S et al.
Cancer, 2025
39876053 (PubMed )
Supplement: supplement_1.pdf
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.
Koukourakis MI et al.
Current Oncology (toronto, Ont.), 2023
An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
Zhou L et al.
Scientific Reports, 2022
35978072 (PubMed )
Supplement: 41598_2022_17791_MOESM3_ESM.xlsx › table
TP53 mutations determined by targeted NGS in breast cancer: a case-control study.
Andrikopoulou A et al.
Oncotarget, 2021
Rad51 paralogs and the risk of unselected breast cancer: A case-control study.
Grešner P et al.
Plos One, 2020
Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer.
Gresner P et al.
Gene, 2012
Select a paper to view details